Non-Performing Assets / Total Loans (Annual)

Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made

IGC Pharma, Inc. (IGC) Non-Performing Assets / Total Loans data is not available.

Quarterly Annual

Figures for fiscal year ending 2024-03-31

Income Statement Financials
Revenue	$1.34M
Net Income	$-13.00M
Cost of Goods Sold	$0.61M
Gross Profit	$0.73M
Operating Expenses	$11.14M
Operating Income	$-9.80M
Non-Operating Income/Expense	$-3.20M
Pre-Tax Income	$-13.00M
Normalized Pre-Tax Income	$-9.65M
Income after Taxes	$-13.00M
Income from Continuous Operations	$-13.00M
Consolidated Net Income/Loss	$-13.00M
Normalized Income after Taxes	$-9.65M
EBIT	$-9.80M
EBITDA	$-9.16M
Weighted-Average Shares Outstanding (Basic)	58.84M
Weighted-Average Shares Outstanding (Diluted)	58.84M
Earnings per Share (EPS) (Basic)	$-0.22
Earnings per Share (EPS) (Diluted)	$-0.22
Balance Sheet Financials
Current Assets	$3.71M
Property, Plant, and Equipment	$3.69M
Long-Term Assets	$6.20M
Total Assets	$9.90M
Current Liabilities	$2.34M
Long-Term Debt	$0.14M
Long-Term Liabilities	$0.24M
Total Liabilities	$2.58M
Common Equity	$7.32M
Tangible Shareholders Equity	$5.71M
Shareholders Equity	$7.32M
Common Shares Outstanding	66.69M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-5.20M
Cash Flow from Investing Activities	$-0.32M
Cash Flow from Financial Activities	$3.52M
Beginning Cash	$3.20M
End Cash	$1.20M
Increase/Decrease in Cash	$-2.00M
Stock-Based Compensation	$1.77M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.58
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.02
Debt to Equity Ratio	0.02
Gross Margin	54.50%
Operating Margin	-728.48%
EBIT Margin	-728.48%
EBITDA Margin	-681.12%
Pre-Tax Profit Margin	-966.54%
Profit Margin	-966.54%
Free Cash Flow	$-5.29M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.14
Inventory Turnover	0.40
Receiveable Turnover	34.49
Days Sales in Receivables	10.58
Return on Equity	-177.57%
Return on Tangible Equity	-227.87%
Return on Assets	-131.29%
Return on Investments	-174.31%
Book Value Per Share	$0.11
Free Cash Flow per Share	$-0.09
Operating Cash Flow per Share	$-0.09

Data from Zacks Investment Research, Inc.